Recurrent herpes simplex virus (HSV) infections afflict millions of Americans. This application proposes to study the pathophysiology of recurrent HSV infection by using an experimental model. Intravaginal HSV inoculation of guinea pigs produces a self-limited genital infection resulting in the establishment of a persistent infection in neural and extraneural tissues. Like humans, guinea pigs exhibit spontaneous subclinical as well as symptomatic recurrent infections and induced recurrent infections follow exposure to ultraviolet (UV) radiation. This unique model of human disease will be used to explore the host and viral factors which are important determinants of latent and recurrent infection. Quantification of the concentration of latent HSV genome in ganglia by a polymerase chain reaction DNA amplification method will be used to investigate the natural history of latent infection. In situ hybridization will be used to examine HSV-1 and HSV-2 transcription in persistently infected tissues. The extent of transcription at neural and extraneural sites will be correlated with the ability of the virus to produce recurrent disease. The differential ability of HSV-1 and HSV-2 to produce recurrent genital infection will be explored using intertypic HSV-1, X HSV-2 mutants. Molecular analyses of these mutants will define the regions of the HSV-2 genome responsible for recurrent genital herpes. Studies of neuron-virus interaction will provide new information regarding the cellular events involved in HSV pathogenesis. Sensory neurons in vivo will be selectively perturbed by pharmacological means to determine how alterations in neuronal function affects latency and recurrent disease. Studies of UV radiation-induced recurrent infection will explore how trigger factors produce recurrent herpes. In situ hybridization will be used to study the effect of UV irradiation on viral transcription in latently infected tissues. Specific immune augmentation studies will explore the relative importance of humoral and cell mediated immune responses, while, pharmacological studies will examine the role of prostaglandins in induced recurrent herpes. The long term goal of this proposal is to expand our understanding of the pathophysiology of latent and recurrent HSV infection, thus ultimately providing new approaches to control an exceedingly common public health problem.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022667-06
Application #
3134103
Study Section
Virology Study Section (VR)
Project Start
1985-09-01
Project End
1994-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
6
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Bourne, Nigel; Pyles, Richard B; Bernstein, David I et al. (2002) Modification of primary and recurrent genital herpes in guinea pigs by passive immunization. J Gen Virol 83:2797-801
Sawtell, N M; Thompson, R L; Stanberry, L R et al. (2001) Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo. J Infect Dis 184:964-71
Stanberry, L R; Cunningham, A L; Mindel, A et al. (2000) Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 30:549-66
Stanberry, L R (2000) Asymptomatic herpes simplex virus shedding and Russian roulette. Clin Infect Dis 30:268-9
Sawtell, N M; Bernstein, D I; Stanberry, L R (1999) A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia. J Infect Dis 180:821-3
Bourne, N; Bernstein, D I; Stanberry, L R (1999) Civamide (cis-capsaicin) for treatment of primary or recurrent experimental genital herpes. Antimicrob Agents Chemother 43:2685-8
Rosenthal, S L; Stanberry, L R; Biro, F M et al. (1997) Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis 24:135-9
Da Costa, X J; Bourne, N; Stanberry, L R et al. (1997) Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Virology 232:1-12
Rosenthal, S L; Biro, F M; Succop, P A et al. (1997) Impact of demographics, sexual history, and psychological functioning on the acquisition of STDS in adolescents. Adolescence 32:757-69
Bourne, N; Stanberry, L R; Bernstein, D I et al. (1996) DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis 173:800-7

Showing the most recent 10 out of 143 publications